Progression of prostate cancer in an 80-year-old maleThe article describes the case of an 80-year-old male patient who experienced a progression of prostate cancer.Amit Mehta MDHem/onc Today
A 70-year-old man with prostate cancer and increased prostate-specific antigen level of 55 ng/mL underwent staging F-fluorocholine PET/CT, which demonstrat... P Lalire,M Zalzali,C Garbar,... - 《Clinical Nuclear Medicine》 被引量: 2发表: 2016年 ...
A 70-year-old man with prostate cancer and increased prostate-specific antigen level of 55 ng/mL underwent staging F-fluorocholine PET/CT, which demonstrated the primary prostate tumor and a focal area corresponding to a 2-cm hypodense...
EP: 1.Case Presentation: An 83-Year-Old Man with Biochemically Recurrent Metastatic Castration-Sensitive Prostate Cancer (mCSPC) EP: 2.First-Line Therapy Options for mCSPC Now Viewing EP: 3.Treatment Approaches for Castration-Sensitive Prostate Cancer with Low Volume Metastatic D...
A 75-year-old Man with Prostate Cancer: Episode1 ByAlicia K. Morgans, MD, MPH Video Expert oncologist Alicia Morgans, MD, MPH, shares details on the diagnosis and management of a patient with metastatic castration-resistant prostate cancer. ...
aIn the case of the 67-year old pensioner with prostate cancer, associated with severe lumbar pain, metastases were excluded with great certainty. Orthopedic treatment in the form of injections, infusions and medication was rather unsuccessful. Periradicular therapy carried out by a radiologist under...
A 72-Year-Old Man With Localized Prostate Cancer-14 Years Later In the first of 136 Clinical Crossroads articles published in JAMA since 1995, Peter C. Albertsen, MD, discussed Mr S, a 72-year-old man with localized pro... T Delbanco,PC Albertsen - 《Jama the Journal of the American...
American Defense Secretary Lloyd Austin recently spent two weeks in a hospital for treatment following an operation for prostate cancer. 英国国王查尔斯最近因前列腺肥大而接受治疗。 美国国防部长劳埃德·奥斯汀最近在接受前列腺癌手术后在医院接受了两周的治疗。 The 70-year-old Austin did not share any ...
In older patients (>65 years of age), those in high radiotherapy use areas had small, but significant improvements in 10-year overall, and cancer-specific survival, suggesting a benefit of radiotherapy in this patient subgroup.doi:10.1038/nrurol.2015.165None...
EP: 1.Introduction: A 66-Year-Old-Man with Metastatic Prostate Cancer EP: 2.Available Monotherapies and Combination Therapies in mCSPC EP: 3.Factors for Consideration when Choosing an ADT Regimen for mCSPC EP: 4.Unmet Needs and Investigational Therapies in mCSPC...